PHARMACOKINETICS AND PHARMACODYNAMICS OF ALPRENOLOL IN TREATMENT OF HYPERTENSION .2. RELATIONSHIP TO ITS EFFECT ON BLOOD-PRESSURE AND PLASMA-RENIN ACTIVITY

被引：23

作者：

COLLSTE, P

HAGLUND, K

FRISKHOLMBERG, M

ORME, MLE

RAWLINS, MD

OSTMAN, J

机构：

[1] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT CLIN PHARMACOL,S-14148 HUDDINGE,SWEDEN

[2] HUDDINGE UNIV HOSP,KAROLINA INST,DEPT MED,S-14148 HUDDINGE,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1976年 / 10卷 / 02期

关键词：

D O I：

10.1007/BF00609465

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：89 / 95

页数：7

共 27 条

[11]

FURBERG C, 1969, ACTA MED SCAND, V186, P447

[12]

HANSSON L, 1973, ACTA MED SCAND, P1

[13] PROPRANOLOL IN HYPERTENSION - REPORT ON 158 PATIENTS TREATED UP TO ONE YEAR [J].

HANSSON, L ;

ABERG, H ;

WESTERLUND, A ;

ROSENHALL, L ;

OLANDER, R ;

MALMCRONA, R ;

HOOD, B .

KLINISCHE WOCHENSCHRIFT, 1972, 50 (07) :364-+

[14] CENTRAL HYPOTENSIVE ACTIVITY OF DL-PROPRANOLOL AND D-PROPRANOLOL [J].

KELLIHER, GJ ;

BUCKLEY, JP .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (09) :1276-&

[15]

LEISHMAN AWD, 1970, BRIT MED J, V4, P343

[16] HYPOTENSIVE AND RENIN-SUPPRESSING ACTIVITIES OF PROPRANOLOL IN HYPERTENSIVE PATIENTS [J].

LEONETTI, G ;

MAYER, G ;

MORGANTI, A ;

TERZOLI, L ;

ZANCHETTI, A ;

BIANCHETTI, G ;

DISALLE, E ;

MORSELLI, PL ;

CHIDSEY, CA .

CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1975, 48 (06) :491-499

[17]

ORME MLE, IN PRESS

[18] TREATMENT OF HYPERTENSION WITH A NEW BETA-BLOCKING AGENT, PINDOLOL (VISKEN) [J].

PERSSON, I ;

ULRICH, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (04) :217-219

[19] USE OF PROPRANOLOL ( INDERAL ) IN TREATMENT OF HYPERTENSION [J].

PRICHARD, BN ;

GILLAM, PMS .

BMJ-BRITISH MEDICAL JOURNAL, 1964, 2 (541) :725-+

[20] STEADY-STATE PLASMA CONCENTRATIONS OF ALPRENOLOL IN MAN [J].

RAWLINS, MD ;

COLLSTE, P ;

FRISKHOL.M ;

LIND, M ;

OSTMAN, J ;

SJOQVIST, F .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (05) :353-356

← 1 2 3 →